GI BLEEDING GASTROINTESTINAL & HEPATOLOGY SOLUTIONS

TREATING GI BLEEDING

The annual burden of illness for GI bleeding in the U.S. is $7.5 billion.1 GI bleeding should be suspected in patients who present with anemia, melena, or hematochezia. Every year, in the U.S., 4.4 million patients present with suspected GI bleeding, but up to 10% remain undiagnosed following EGD/colonoscopy.2,3


BARRX RADIOFREQUENCY ABLATION SYSTEM

Barrx Radiofrequency Ablation System Catheter Family

Radiofrequency ablation is a minimally-invasive procedure aimed to treat bleeding by providing coagulation in conditions such as gastric antral vascular ectasia (GAVE) and radiation proctitis (RP).

1

Peery A, Dellon E, Lund J, Crockett S, Mcgowan C, Bulsiewicz W, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179-87.

2

Zhu A, Kaneshiro M, Kaunitz J. Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Digestive Disease Sciences. 2010;55:548-559.

3

Internal Data–Internal Market Model. July, 2015. Data on file.

*

Image does not represent all components of the system